Parallel insulin resistance and beta cell decompensation in Type 2 diabetes

Diabetologia

Volumn 47, Issue 5, 2004, Pages 782-793

  Tripathy, D ^a   Eriksson, K F ^a   Orho Melander, M ^a   Fredriksson, J ^a   Ahlqvist, G ^a   Groop, L ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Beta cell function; Calpain 10 gene; Disposition index; Endogenous glucose production; Glucose tolerance; Hepatic insulin sensitivity; Insulin resistance; Insulin secretion; Type 2 Diabetes

Indexed keywords

GLUCOSE; INSULIN; CALPAIN; CALPAIN 10; FATTY ACID;

AGED; ARTICLE; CALORIMETRY; CONTROLLED STUDY; DIABETOGENESIS; EVALUATION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SAMPLE SIZE; ADULT; BLOOD; BODY SIZE; DIABETES MELLITUS; EXERCISE TEST; GENETIC PREDISPOSITION; GENETICS; GLUCOSE INTOLERANCE; METABOLISM; OXYGEN CONSUMPTION; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; BODY SIZE; CALPAIN; DIABETES MELLITUS; EXERCISE TEST; FATTY ACIDS, NONESTERIFIED; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; OXYGEN CONSUMPTION;

EID: 2942536810     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1393-8     Document Type: Article

References (54)

1. Beck-Nielsen H, Groop LC (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721
2. DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
3. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
4. Reaven GM, Hollenbeck CB, Chen YD (1989) Relationship between glucose tolerance, insulin secretion, and insu-lin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55
5. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246
6. Ferrannini E, Groop LC (1989) Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 5:711-726
7. Pigon J, Giacca A, Ostenson CG, Lam L, Vranic M, Efendic S (1996) Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients. J Clin Endocrinol Metab 81:3702-3708
8. Jeng CY, Sheu WH, Fuh MM, Chen YD, Reaven GM (1994) Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 43:1440-1444
9. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J (1998) Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624
10. Groop LC, Widen E, Ferrannini E (1993) Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326-1331
11. Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
12. Eriksson KF, Lindgarde F (1991) Prevention of type 2 (non-insulin- dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 34:891-898
13. Eriksson KF, Lindgarde F (1998) No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia 41:1010-1016
14. Horikawa Y, Oda N, Cox NJ et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
15. Baier LJ, Permana PA, Yang X et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73
16. WHO (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28:1039-1057
17. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
18. Talluri T, Lietdke RJ, Evangelisti A, Talluri J, Maggia G (1999) Fat-free mass qualitative assessment with bioelectric impedance analysis (BIA). Ann NY Acad Sci 873:94-98
19. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
20. 3H]-glucose infusion and labelled or unlabelled glucose infusates. Diabet Med 9:840-849
21. Zambon A, Hashimoto SI, Brunzell JD (1993) Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34:1021-1028
22. Larsson H, Ahren B (1998) Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41:772-777
23. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328
24. Grill V (1981) Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol 240:E24-E31
25. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
26. Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, Groop L (2002) Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51:2658-2664
27. Evans DJ, Murray R, Kissebah AH (1984) Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest 74:1515-1525
28. Waldhausl W, Roden M (2000) The effects of free fatty acids on glucose transport and phosphorylation in human skeletal muscle. Curr Opin Endocrinol Diabetes 7:211-216
29. Baldeweg SE, Golay A, Natali A, Balkau B, Del Prato S, Coppack SW (2000) Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest 30:45-52
30. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV (1997) Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol 17:64-71
31. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210
32. Krssak M, Falk Petersen K, Dresner A et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113-116
33. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1666
34. Jacob S, Machann J, Rett K et al. (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119
35. Dresner A, Laurent D, Marcucci M et al. (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259
36. Griffin ME, Marcucci MJ, Cline GW et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270-1274
37. Cline GW, Petersen KF, Krssak M et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240-246
38. Meyer C, Dostou J, Nadkarni V, Gerich J (1998) Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. Am J Physiol 275:F915-F921
39. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028
40. Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229
41. Hennes MM, Dua A, Kissebah AH (1997) Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62
42. Svedberg J, Stromblad G, Wirth A, Smith U, Bjorntorp P (1991) Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 88:2054-2058
43. Bavenholm PN, Pigon J, Ostenson CG, Efendic S (2001) Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes 50:1449-1454
44. Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476-1483
45. McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18
46. Shimabukuro M, Zhou YT, Lee Y, Unger RH (1998) Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547-3550
47. Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z (2001) Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 50 [Suppl 1]:S52-S57
48. Mulder H, Holst LS, Svensson H et al. (1999) Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes 48:228-232
49. Harndahl L, Jing XJ, Ivarsson R et al. (2002) Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin. J Biol Chem 277:37446-37455
50. Evans JC, Frayling TM, Cassell PG et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69:544-552
51. Garant MJ, Kao WH, Brancati F et al. (2002) SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 51:231-237
52. Sreenan SK, Zhou YP, Otani K et al. (2001) Calpains play a role in insulin secretion and action. Diabetes 50:2013-2020
53. Rasmussen SK, Urhammer SA, Berglund L et al. (2002) Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51:3561-3567
54. Horikawa Y, Oda N, Yu L et al. (2003) Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 88:244-247